| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/28/2005 | US20050164964 Mixture of a nucleic acid and a chitosan with branching groups attached to the amino group, selected from alkyl groups with 2 or more carbon atoms, monosaccharides, oligosaccharides or polysaccharides; gene therapy, genetic vaccines, antisense therapy, anticarcinogenic agents, autoimmune diseases |
| 07/28/2005 | US20050164963 Components for producing amphoteric liposomes |
| 07/28/2005 | US20050164962 Method for the identification of tissue-specific regulatory sequences |
| 07/28/2005 | US20050164961 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 07/28/2005 | US20050164948 Methods of treatment with prosaposin-derived peptides |
| 07/28/2005 | US20050164946 Mammalian somatoliberin for use in the prevention and treatment of anemia, cachexia, aberrant wound and bone healing, osteoporosis and obesity; veterinary medicine |
| 07/28/2005 | US20050164941 Use in impacting plant microbial pathogens and in enhancing plant disease resistance to microbial pathogens |
| 07/28/2005 | US20050164940 Fus6 family antimicrobial polypeptides and their uses |
| 07/28/2005 | US20050164939 Nucleotide sequences coding polypeptide associated with the generation of disease resistant plants |
| 07/28/2005 | US20050164936 Antiinflammatory and antitumor agents; human T-cell leukemia/lymphoma virus and lymphadenopathy associated virus treatment; angiogenic- or hematopoiesis-related diseases; medical diagnosis |
| 07/28/2005 | US20050164932 Amino acid substitution in position 36; brain bleeding, hemorrhage, trauma or injury; genetic engineering and expression; biodrugs, anticoagulants |
| 07/28/2005 | US20050164930 Multimeric protein with linker having sequence ProValSerGlyProArg; [Gly2]hGLP-2 is produced from a multimeric precursor; genetic engineering and expression; biodrugs |
| 07/28/2005 | US20050164926 Novel recombinant anticoagulant proteins |
| 07/28/2005 | US20050164917 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2005 | US20050164906 Inhibitors of the Mitogen Activated Protein Kinases (MAPKs) pathway activated by Ras/Raf complex using GILZ (glucocorticoid-Induced Leucine Zipper) protein related compounds as inhibitors of Raf/Ras-mediated signal transduction; anticarcinogenic agents |
| 07/28/2005 | US20050164394 Methods and means for producing efficient silencing construct using recombinational cloning |
| 07/28/2005 | US20050164393 Method for identifying genes encoding signal sequences |
| 07/28/2005 | US20050164392 Expression vector comprising adenoviral regulatory sequences for use as tool in enhancement of heterologous gene transfer and viral expression in cells |
| 07/28/2005 | US20050164391 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164387 Propagating lymphocytic cells without using large excesses of peripheral blood mononuclear cells (PBMC) or epstein barr virally-transformed lymphoblastoid cells (LCL); immunotherapy |
| 07/28/2005 | US20050164386 Immortalized embryonic stem cells comprising adenoviral early genes for use as bioreactors in the production of proteins that benefit from post-translational or peri-translational modifications |
| 07/28/2005 | US20050164385 Embryonic stem cells having genetic modifications |
| 07/28/2005 | US20050164383 Undifferentiated progenitor cells invitro differentiation into somatic cell tissues; transplantation and treatment of congenital disorders |
| 07/28/2005 | US20050164382 Differentiation protocol for making human cardiomyocytes |
| 07/28/2005 | US20050164369 Expression vector comprising heat shock and phosphoenolpyruvate carboxykinase regulatory sequences for use as tool in enhancing exogenous gene expression |
| 07/28/2005 | US20050164368 Transgenic, grampositive bacteria comprising expression vector coding viricidal agent for use in treatment and prevention of gastrointestinal disorders in infants |
| 07/28/2005 | US20050164366 Tissue plasminogen activator-like protease |
| 07/28/2005 | US20050164365 Genetically modified ecarin and process for producing the same |
| 07/28/2005 | US20050164360 plasmid vectors comprising marker genes operably linked to promoters functional in actinobacillus, origin of replication functional in actinobacillus, a second promoter isolated from actinobacillus, and cloning site downstream from the second promoter |
| 07/28/2005 | US20050164354 Lactic acid bacteria overproducing exopolysaccharides |
| 07/28/2005 | US20050164353 Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids |
| 07/28/2005 | US20050164352 Immunoglobulin interleukin fusion for activating lymphoid precursor cells; treatment and prevention of infection |
| 07/28/2005 | US20050164351 Expression of glycosyltransferase in Aspergillus |
| 07/28/2005 | US20050164349 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA Polymerase and thereby prevent the assembly of a poised transcriptional complex |
| 07/28/2005 | US20050164348 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs |
| 07/28/2005 | US20050164347 plasmid vectors transformed by electroporation to provide a means for gene overexpression of proteins and confer antibiotic resistance |
| 07/28/2005 | US20050164346 Actinobacillus succinogenes shuttle vector and methods of use |
| 07/28/2005 | US20050164342 Cloned glutamic acid decarboxylase |
| 07/28/2005 | US20050164341 Methods of purification of cytochrome p450 proteins and of their crystallizing |
| 07/28/2005 | US20050164335 Methods and organisms for production of b6 vitamers |
| 07/28/2005 | US20050164313 Methods and compositions for the detection of cervical cancer |
| 07/28/2005 | US20050164305 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 07/28/2005 | US20050164298 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor(ghs) |
| 07/28/2005 | US20050164291 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/28/2005 | US20050164287 Nucleic acid ladders |
| 07/28/2005 | US20050164286 Nucleic acid concentration quantitative analysis chip, nucleic acid concentration quantitative analysis apparatus, and nucleic acid concentration quantitative analysis method |
| 07/28/2005 | US20050164284 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders |
| 07/28/2005 | US20050164282 Synthetic cell-or tissue-specific transcriptional regulatory regions |
| 07/28/2005 | US20050164280 Twisted gastrulation (TSG) polypeptide for designing drugs to regulate hematopoietic stem cell generation; treating blood disorders |
| 07/28/2005 | US20050164279 Secreted and transmembrane polypetides and nucleic acids encoding the same |
| 07/28/2005 | US20050164276 Nucleotide sequences coding serine protease like polypeptides for use in diagnosis and treatment of infection, diabetes, obesity and infertility |
| 07/28/2005 | US20050164274 Preparing microarray which utilizesneural network or statistical based pattern recognition techniques to quantiify and identify components of biosystems; non-label detection systems; mass increase and biopolymer detection |
| 07/28/2005 | US20050164273 Using weighted color ratio to accurately determine gene expression patterns; bioinformatics; computer programs |
| 07/28/2005 | US20050164271 Antisense agents for treatment of adrenocorticotropic hormone dysregulation; gene expression inhibition; antidiabetic agents; anticholesterol agents; antilipemic agents |
| 07/28/2005 | US20050164270 Methods and system for providing a polymorphism database |
| 07/28/2005 | US20050164269 Polynucleotide; nucleotide sequence encoding a polypeptide having inositol 1,3,4-triphosphate 5/6-kinase activity |
| 07/28/2005 | US20050164268 Oncology diagnosis; gene overexpression/underexpression; tumor suppressor genes |
| 07/28/2005 | US20050164267 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 07/28/2005 | US20050164266 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/28/2005 | US20050164263 identification of amino acid sequences and proteins related to MAP/ERK subfamily; gene chip; transgenic nonhuman animal; nucleic acid vector; expression in larynx epithelium, Wilms' tumors of the kidney, pancreas adenocarcinomas, fetal brain, and hippocampus; models for human therapeutic targets |
| 07/28/2005 | US20050164260 Using lysozyme, ribonuclease, metal chelators and non-ionic detergents to isolate organismal nucleic acid sequences; DNA extraction |
| 07/28/2005 | US20050164256 Treating and/or preventing cornary heart defects via administration of forkhead transcription factor; gene therapy |
| 07/28/2005 | US20050164255 solid phase synthesis using a mixture of nucleotides and nucleotide analogs, and a supported target DNA and DNA polymerase; template directed extension of a primer; spectrum analysis |
| 07/28/2005 | US20050164253 Using blood lymphocyte DNA as diagnostic tool in detection of autoimmune disease |
| 07/28/2005 | US20050164252 Methods using non-genic sequences for the detection, modification and treatment of any disease or improvement of functions of a cell |
| 07/28/2005 | US20050164251 Novel human transporter proteins and polynucleotides encoding the same |
| 07/28/2005 | US20050164250 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050164247 isolated nucleic acid molecule wherein CD4+T cells over-expressing said nucleic acid sequence exhibits a reduction in CD3 and CD28 mediated T-cell proliferation; vector and host cell transformed with said nucleic acid |
| 07/28/2005 | US20050164241 Cell-free blood serum/plasma from pregnant woman for use in detection of rhesus antigen D (RHD) and diagnosis of hemolytic disease of fetus and/or newborn |
| 07/28/2005 | US20050164240 Eucaryotic transcription factor antisense nucleotides for detection and treatment of cancer; antitumor agents |
| 07/28/2005 | US20050164239 Optical sorting method |
| 07/28/2005 | US20050164234 Antisense therapy; gene expression inhibition |
| 07/28/2005 | US20050164233 Compositions, kits and methods for identification and modulation of type I diabetes |
| 07/28/2005 | US20050164232 Reg-like protein |
| 07/28/2005 | US20050164224 Cancers such as lymphomas, carcinoma, ovarian cancer, melanoma, colorectal cancer, prostate cancer, lung cancer, bladder cancer |
| 07/28/2005 | US20050164222 Optimization of immunomodulatory properties of genetic vaccines |
| 07/28/2005 | US20050164221 Novel human membrane proteins and polynucleotides encoding the same |
| 07/28/2005 | US20050164219 Diagnostic probe comprising template and target binding regions for use in polymerase chain reaction amplification |
| 07/28/2005 | US20050164215 Methods for rapid purification of nucleic acids for subsquent analysis by mass spectrometery by solution capture |
| 07/28/2005 | US20050164214 Methods for protein interaction determination |
| 07/28/2005 | US20050164213 Replicating nucleotide sequences without the need for exogenously-added oligonucleotide primers or terminal protein covalently bound to either 5' end; polymerase replication |
| 07/28/2005 | US20050164212 Modulation of gene expression using DNA-RNA hybrids |
| 07/28/2005 | US20050164210 Regulated polymerase III expression systems and related methods |
| 07/28/2005 | US20050164209 Using phenotypic variance to identify bioactive oligomers; gene expression analysis; RNA interference; |
| 07/28/2005 | US20050164208 Storage of genetic information |
| 07/28/2005 | US20050164203 analyzing genomic DNA to determine the presence of repeat sequences and comparing them with corresponding repeat sequences of putative ancestors, to determine the lineage of an individual |
| 07/28/2005 | US20050164201 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses therof |
| 07/28/2005 | US20050164200 Method for detecting biochemical reactant biochip |
| 07/28/2005 | US20050164197 Using matrix protein concentration to detect liver, cardiovascular and kidney disorders |
| 07/28/2005 | US20050164196 Using allelic variation in interleukin expression as diagnostic tool in prediciting human response to imatinib mesylate; enzyme inhibitors and cancer treatment; immunodiagnostics |
| 07/28/2005 | US20050164194 Growth regulating proteins |
| 07/28/2005 | US20050164192 Transgenic plants expressing enzymes involved in fatty acid biosynthesis |
| 07/28/2005 | US20050164191 Complex comprising at least two biospecific elements separated by a nucleic acid linker e.g. for identification of drug delivery candidates. combinatorial library of such complexes |
| 07/28/2005 | US20050164186 Analyzing and determining in a population prokaryotic host cells having gene expression for modualtion methyltransferases, whether viable cells express an active mutant hydrolase enzymes; genetic engineering |
| 07/28/2005 | US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/28/2005 | US20050164184 Hybridization portion control oligonucleotide and its uses |
| 07/28/2005 | US20050164182 Nucleoside comprising reporter molecule cleavable by hydrolase such as esterases, phosphatases, peptidases, penicillin amidases, glycosidases, and phosphorylases; limits polymerase activity; sequencing; solid phase synthesis |
| 07/28/2005 | US20050164180 Phage diplay libraries of human vh fragments |
| 07/28/2005 | US20050164178 Starch branching enzyme |
| 07/28/2005 | US20050164175 Respiratory Syncytial Virus; vectors containing heterogeneity genes |